发明授权
US09176150B2 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
有权
淀粉样蛋白β(1-42)寡聚体,其衍生物和抗体,其制备方法和用途
- 专利标题: Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
- 专利标题(中): 淀粉样蛋白β(1-42)寡聚体,其衍生物和抗体,其制备方法和用途
-
申请号: US13195533申请日: 2011-08-01
-
公开(公告)号: US09176150B2公开(公告)日: 2015-11-03
- 发明人: Heinz Hillen , Andreas Striebinger , Carsten Krantz , Achim Moeller , Reinhold Mueller
- 申请人: Heinz Hillen , Andreas Striebinger , Carsten Krantz , Achim Moeller , Reinhold Mueller
- 申请人地址: DE Wiesbaden
- 专利权人: AbbVie Deutschland GmbH & Co. KG
- 当前专利权人: AbbVie Deutschland GmbH & Co. KG
- 当前专利权人地址: DE Wiesbaden
- 代理机构: Michael Best & Friedrich LLP
- 代理商 Lisa V. Mueller
- 优先权: DE10303974 20030131
- 主分类号: C07K16/18
- IPC分类号: C07K16/18 ; G01N33/68 ; A61K38/17 ; C07K14/47 ; G01N33/53 ; A61K39/395
摘要:
The invention relates to neuromodulatory oligomers of the amyloid-β(1-42) protein, a particular production method, by means of which the oligomer can be obtained in a reproducible manner at high yield, the use of the oligomers as diagnostic and therapeutics agents, for the generation of oligomer-specific antibodies and for the discovery of substances which can interact with the oligomers and in the formation thereof. Corresponding methods for the production of the antibodies and for discovery of the substances are also disclosed as are the antibodies themselves and the use of the antibodies or substances as diagnostic and therapeutic agents. The invention further relates to derivatives of the oligomers and oligomers based on abbreviated forms of the amyloid-β(1-42) proteins, the production and use thereof.
公开/授权文献
信息查询